通过整合反向网络药理学,分子对接和分子动力学来探索抑郁症和潜在抗抑郁药的病变发生
Zhongwen Lu1, Fei Gao1, Fei Teng1
1College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Medicine
|November 7, 2023
概括
传统中医药提供有效的抑郁症治疗,副作用很少. 这项研究使用了网络药理学和模拟来确定各种抑郁类型的关键草药和成分.
科学领域:
- 综合医学是一个整体的医学.
- 计算生物学 计算生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抑郁症是一个重大的全球健康威胁,有效治疗方法有限.
- 传统中医 (TCM) 提供了一个有前途的替代品,副作用较少.
- 确定抑郁症的特定TCM成分需要科学验证.
研究的目的:
- 通过反向网络药理学和计算机模拟,识别有效的TCM成分和治疗抑郁症的草药.
- 通过计算药物评估和分子对接来验证已识别的化合物的治疗潜力.
- 根据其属性和度线对针对性抑郁症治疗进行TCM草药的分类.
主要方法:
- 来自基因表达综合数据库的差异基因表达分析.
- 使用STRING数据库构建蛋白质与蛋白质相互作用网络.
- 通过TCMSP数据库对TCM成分进行选,然后进行网络分析.
- 使用瑞士ADME和ADMETlab,分子对接和分子动力学模拟进行药物评估.
主要成果:
- 确定了与抑郁症发病相关的关键基因 (例如,SPP1,SERPINE1,CCNB1,CCL3).
- 奎尔塞丁,卢特奥林和阿皮基宁被验证为潜在的治疗成分.
- 顶级草药与肝 meridian 联系在一起,并具有尖的味道,支持TCM 理论.
- 特定的草药配方与不同类型的抑郁症有关 (Qi停滞,喘,阴缺乏症).
结论:
- 这项研究成功地确定了关键目标和有效的TCM药物治疗抑郁症.
- 计算方法为验证TCM疗效提供了一个强大的框架.
- 这些发现提供了基于证据的草药混合参考,用于治疗TCM中各种抑郁模式.
相关概念视频
Antidepressant Drugs: Overview
524
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
524
Antidepressant Drugs: MAOIs and Other Agents
252
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
252
Depression: Overview
255
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
255
G-protein Coupled Receptors
119.9K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
119.9K
Long-term Depression
30.9K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
30.9K
Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K


